Stem-cell ruling

摘要

The US Food and Drug Administration (FDA) has now been given legal backing for its attempts to regulate a US clinic that offers therapies involving a patient's processed stem cells. Such treatments can now be classified as drugs, a US District Court in Washington DC ruled on 23 July, in relation to the FDAs injunction against Regenerative Sciences, a stem-cell clinic in Broomfield, Colorado.